These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1347536)

  • 21. Mechanisms and Characteristics of Sulfonylureas and Glinides.
    Lv W; Wang X; Xu Q; Lu W
    Curr Top Med Chem; 2020; 20(1):37-56. PubMed ID: 31884929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulfonylureas in the treatment of diabetes mellitus--1985.
    Gerich JE
    Mayo Clin Proc; 1985 Jul; 60(7):439-43. PubMed ID: 3925246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
    Wolffenbuttel BH; van Haeften TW
    Drugs; 1995 Aug; 50(2):263-88. PubMed ID: 8521759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined insulin-sulfonylurea therapy in treatment of NIDDM.
    Groop LC; Groop PH; Stenman S
    Diabetes Care; 1990 Aug; 13 Suppl 3():47-52. PubMed ID: 2209344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulfonylureas.
    Zimmerman BR
    Endocrinol Metab Clin North Am; 1997 Sep; 26(3):511-22. PubMed ID: 9314012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM?
    Melander A; Bitzén PO; Sartor G; Scherstén B; Wåhlin-Boll E
    Diabetes Care; 1990 Aug; 13 Suppl 3():53-8. PubMed ID: 2209345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoglycemic drugs.
    White JR; Campbell RK
    Clin Podiatr Med Surg; 1992 Apr; 9(2):239-55. PubMed ID: 1586902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral sulfonylureas on the spectrum of defects in non-insulin-dependent diabetes mellitus.
    Owens DR
    Am J Med; 1985 Aug; 79(2B):27-32. PubMed ID: 3929599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral hypoglycemic agents in the treatment of type II diabetes.
    Tal A
    Am Fam Physician; 1993 Nov; 48(6):1089-95. PubMed ID: 8237731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.
    Kolterman OG; Olefsky JM
    Diabetes Care; 1984; 7 Suppl 1():81-8. PubMed ID: 6376033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type II diabetes: role of first- and second-generation drugs.
    Washington SE; Mazzaferri EL
    Geriatrics; 1986 Nov; 41(11):51-6, 59-60, 64. PubMed ID: 3770483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined insulin and sulfonylurea treatment in diabetes mellitus].
    Ravina A; Minuhin O
    Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394
    [No Abstract]   [Full Text] [Related]  

  • 38. What nurses don't know about managing NIDDM.
    Wilson BA
    Medsurg Nurs; 1994 Apr; 3(2):152-4. PubMed ID: 8173627
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined therapy with insulin and oral hypoglycemic agents in diabetes mellitus].
    Takamatsu J
    Nihon Rinsho; 1990 Dec; 48 Suppl():1031-7. PubMed ID: 2086864
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated plasma levels of pancreastatin (PST) in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Funakoshi A; Tateishi K; Shinozaki H; Matsumoto M; Wakasugi H
    Regul Pept; 1990 Sep; 30(2):159-64. PubMed ID: 2274680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.